The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis

One critical event of tumour invasion that signals the initiation of the metastatic cascade is thought to be interaction of the tumour cell with the basement membrane. Basement membranes may also pose as barriers to tumour cell invasion at multiple points later in the metastatic cascade, including during the processes of vascular infiltration and extravasation. Thus, an important proteolytic event in the metastatic cascade, and also angiogenesis, appears to be degradation of basement membrane components. A specific class of extracellular matrix degrading metalloenzymes, the matrix metalloproteases, and their endogenous inhibitors, the tissue inhibitors of metalloproteases, are thought to have a role in the creation of the proteolytic defect in basement membrane type IV collagen. We will review the evidence which indicates that matrix metalloproteases and tissue inhibitors of metalloproteases are essential for tumour cell invasion and angiogenesis. The regulation of matrix metalloproteases will be discussed, including gene activation and transcription, messenger ribonucleic acid (mRNA) stability, binding of proenzymes to cell membranes and/or matrix components, proenzyme activation, and inactivation by endogenous inhibitors. We will also discuss the mechanism for tissue inhibitor of metalloproteases-mediated inhibition of tumour invasion and angiogenesis. This appears, at least in part, to be through inhibition of protease activity required for cellular invasion, although recent observations suggest that tissue inhibitors of metalloproteases affect other distinct groups of biological activities through mechanisms other than matrix metalloprotease inhibition.

This article has been cited by other articles:

				T. A. O'Mara, J. A. Clements, and A. B. Spurdle The Use of Predictive or Prognostic Genetic Biomarkers in Endometrial and Other Hormone-Related Cancers: Justification for Extensive Candidate Gene Single Nucleotide Polymorphism Studies of the Matrix Metalloproteinase Family and their Inhibitors Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2352 - 2365. [Abstract] [Full Text] [PDF]

				A. C. Aplin, W. H. Zhu, E. Fogel, and R. F. Nicosia Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis Am J Physiol Cell Physiol, August 1, 2009; 297(2): C471 - C480. [Abstract] [Full Text] [PDF]

				I. M. Porto, L. B. Rocha, M. A. Rossi, and R. F. Gerlach In Situ Zymography and Immunolabeling in Fixed and Decalcified Craniofacial Tissues J. Histochem. Cytochem., July 1, 2009; 57(7): 615 - 622. [Abstract] [Full Text] [PDF]

				A. Lipton, K. Leitzel, H. A. Chaudri-Ross, D. B. Evans, S. M. Ali, L. Demers, P. Hamer, S. Brown-Shimer, K. Pierce, V. Gaur, et al. Serum TIMP-1 and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen in Metastatic Breast Cancer J. Clin. Oncol., June 1, 2008; 26(16): 2653 - 2658. [Abstract] [Full Text] [PDF]

				C.-J. Weng, C.-F. Chau, Y.-S. Hsieh, S.-F. Yang, and G.-C. Yen Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-{kappa}B and AP-1 Carcinogenesis, January 1, 2008; 29(1): 147 - 156. [Abstract] [Full Text] [PDF]

				Y. Wang, H. Rosen, D. K. Madtes, B. Shao, T. R. Martin, J. W. Heinecke, and X. Fu Myeloperoxidase Inactivates TIMP-1 by Oxidizing Its N-terminal Cysteine Residue: AN OXIDATIVE MECHANISM FOR REGULATING PROTEOLYSIS DURING INFLAMMATION J. Biol. Chem., November 2, 2007; 282(44): 31826 - 31834. [Abstract] [Full Text] [PDF]

				J.-G. Jiang, Y.-G. Ning, C. Chen, D. Ma, Z.-J. Liu, S. Yang, J. Zhou, X. Xiao, X. A. Zhang, M. L. Edin, et al. Cytochrome P450 Epoxygenase Promotes Human Cancer Metastasis Cancer Res., July 15, 2007; 67(14): 6665 - 6674. [Abstract] [Full Text] [PDF]

				L. Thiberville, S. Moreno-Swirc, T. Vercauteren, E. Peltier, C. Cave, and G. Bourg Heckly In Vivo Imaging of the Bronchial Wall Microstructure Using Fibered Confocal Fluorescence Microscopy Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 22 - 31. [Abstract] [Full Text] [PDF]

				Y. Miyata, T. Iwata, K. Ohba, S. Kanda, M. Nishikido, and H. Kanetake Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tissue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implications and Clinical Significance for Invasion and Metastasis Clin. Cancer Res., December 1, 2006; 12(23): 6998 - 7003. [Abstract] [Full Text] [PDF]

				C. Chetty, P. Bhoopathi, P. Joseph, S. Chittivelu, J. S. Rao, and S. Lakka Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol. Cancer Ther., September 1, 2006; 5(9): 2289 - 2299. [Abstract] [Full Text] [PDF]

				O. Graesslin, A. Cortez, R. Fauvet, M. Lorenzato, P. Birembaut, and E. Darai Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study Ann. Onc., April 1, 2006; 17(4): 637 - 645. [Abstract] [Full Text] [PDF]

				W. H. Sun, Y. L. Sun, R. N. Fang, Y. Shao, H. C. Xu, Q. P. Xue, G. X. Ding, and Y. L. Cheng Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-9 in Gastric Carcinoma and its Correlation with Angiogenesis Jpn. J. Clin. Oncol., December 1, 2005; 35(12): 707 - 713. [Abstract] [Full Text] [PDF]

				D. H. Geho, R. W. Bandle, T. Clair, and L. A. Liotta Physiological Mechanisms of Tumor-Cell Invasion and Migration Physiology, June 1, 2005; 20(3): 194 - 200. [Abstract] [Full Text] [PDF]

				D. Iglesias, J. Alegre, C. Aleman, E. Ruiz, T. Soriano, L. I. Armadans, R. M. Segura, A. Angles, J. Monasterio, and T. Fernandez de Sevilla Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions Eur. Respir. J., January 1, 2005; 25(1): 104 - 109. [Abstract] [Full Text] [PDF]

				S. Ishikawa, K. Takenaka, K. Yanagihara, R. Miyahara, Y. Kawano, Y. Otake, S. Hasegawa, H. Wada, and F. Tanaka Matrix Metalloproteinase-2 Status in Stromal Fibroblasts, Not in Tumor Cells, Is a Significant Prognostic Factor in Non-Small-Cell Lung Cancer Clin. Cancer Res., October 1, 2004; 10(19): 6579 - 6585. [Abstract] [Full Text] [PDF]

				D. P. Basile, K. Fredrich, D. Weihrauch, N. Hattan, and W. M. Chilian Angiostatin and matrix metalloprotease expression following ischemic acute renal failure Am J Physiol Renal Physiol, May 1, 2004; 286(5): F893 - F902. [Abstract] [Full Text] [PDF]

				O. R.F. Mook, C. Van Overbeek, E. G. Ackema, F. Van Maldegem, and W. M. Frederiks In Situ Localization of Gelatinolytic Activity in the Extracellular Matrix of Metastases of Colon Cancer in Rat Liver Using Quenched Fluorogenic DQ-gelatin J. Histochem. Cytochem., June 1, 2003; 51(6): 821 - 829. [Abstract] [Full Text] [PDF]

				C. M. Hartog, J. A. Wermelt, C. O. Sommerfeld, W. Eichler, K. Dalhoff, and J. Braun Pulmonary Matrix Metalloproteinase Excess in Hospital-acquired Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 593 - 598. [Abstract] [Full Text] [PDF]

				M. Razandi, A. Pedram, S. T. Park, and E. R. Levin Proximal Events in Signaling by Plasma Membrane Estrogen Receptors J. Biol. Chem., January 17, 2003; 278(4): 2701 - 2712. [Abstract] [Full Text] [PDF]

				W. Li, K. Tanaka, Y. Chiba, T. Kimura, K. Morioka, T. Uesaka, A. Ihaya, M. Sasaki, T. Tsuda, and N. Yamada Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H23 - H30. [Abstract] [Full Text] [PDF]

				A. Chlenski, S. Liu, S. E. Crawford, O. V. Volpert, G. H. DeVries, A. Evangelista, Q. Yang, H. R. Salwen, R. Farrer, J. Bray, et al. SPARC Is a Key Schwannian-derived Inhibitor Controlling Neuroblastoma Tumor Angiogenesis Cancer Res., December 15, 2002; 62(24): 7357 - 7363. [Abstract] [Full Text] [PDF]

				S. V. Brodsky, K. Malinowski, M. Golightly, J. Jesty, and M. S. Goligorsky Plasminogen Activator Inhibitor-1 Promotes Formation of Endothelial Microparticles With Procoagulant Potential Circulation, October 29, 2002; 106(18): 2372 - 2378. [Abstract] [Full Text] [PDF]

				R. KALLURI Discovery of Type IV Collagen Non-collagenous Domains as Novel Integrin Ligands and Endogenous Inhibitors of Angiogenesis Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 255 - 266. [Abstract] [PDF]

				R. Engers, E. Springer, F. Michiels, J. G. Collard, and H. E. Gabbert Rac Affects Invasion of Human Renal Cell Carcinomas by Up-regulating Tissue Inhibitor of Metalloproteinases (TIMP)-1 and TIMP-2 Expression J. Biol. Chem., November 2, 2001; 276(45): 41889 - 41897. [Abstract] [Full Text] [PDF]

				W. Li, Y. Chiba, T. Kimura, K. Morioka, T. Uesaka, A. Ihaya, and R. Muraoka Transmyocardial laser revascularization induced angiogenesis correlated with the expression of matrix metalloproteinases and platelet-derived endothelial cell growth factor Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 156 - 163. [Abstract] [Full Text] [PDF]

				P. Jurasz, G. Sawicki, M. Duszyk, J. Sawicka, C. Miranda, I. Mayers, and M. W. Radomski Matrix Metalloproteinase 2 in Tumor Cell-induced Platelet Aggregation: Regulation by Nitric Oxide Cancer Res., January 1, 2001; 61(1): 376 - 382. [Abstract] [Full Text]

				N. Di Girolamo, D. Wakefield, and M. T. Coroneo Differential Expression of Matrix Metalloproteinases and Their Tissue Inhibitors at the Advancing Pterygium Head Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4142 - 4149. [Abstract] [Full Text]

				D. Huang, J. L. Rutkowski, G. M. Brodeur, P. M. Chou, J. L. Kwiatkowski, A. Babbo, and S. L. Cohn Schwann Cell-conditioned Medium Inhibits Angiogenesis Cancer Res., November 1, 2000; 60(21): 5966 - 5971. [Abstract] [Full Text]

				E. K. Rowinsky, R. Humphrey, L. A. Hammond, C. Aylesworth, L. Smetzer, M. Hidalgo, M. Morrow, L. Smith, A. Garner, J. M. Sorensen, et al. Phase I and Pharmacologic Study of the Specific Matrix Metalloproteinase Inhibitor BAY 12-9566 on a Protracted Oral Daily Dosing Schedule in Patients With Solid Malignancies J. Clin. Oncol., January 5, 2000; 18(1): 178 - 178. [Abstract] [Full Text] [PDF]

				C. Fernandez-Patron, M. W. Radomski, and S. T. Davidge Vascular Matrix Metalloproteinase-2 Cleaves Big Endothelin-1 Yielding a Novel Vasoconstrictor Circ. Res., November 12, 1999; 85(10): 906 - 911. [Abstract] [Full Text] [PDF]

				A. Vacca, D. Ribatti, M. Presta, M. Minischetti, M. Iurlaro, R. Ria, A. Albini, F. Bussolino, and F. Dammacco Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma Blood, May 1, 1999; 93(9): 3064 - 3073. [Abstract] [Full Text] [PDF]

				S. Lukomski, C. A. Montgomery, J. Rurangirwa, R. S. Geske, J. P. Barrish, G. J. Adams, and J. M. Musser Extracellular Cysteine Protease Produced by Streptococcus pyogenes Participates in the Pathogenesis of Invasive Skin Infection and Dissemination in Mice Infect. Immun., April 1, 1999; 67(4): 1779 - 1788. [Abstract] [Full Text] [PDF]

				G Cox, W P Steward, and K J O'Byrne The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer Thorax, February 1, 1999; 54(2): 169 - 179. [Full Text]

				B. Kraling, D. Wiederschain, T Boehm, M Rehn, J. Mulliken, and M. Moses The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro J. Cell Sci., January 5, 1999; 112(10): 1599 - 1609. [Abstract] [PDF]

				K. Airola, M. Ahonen, N. Johansson, P. Heikkilä, J. Kere, V.-M. Kähäri, and U. K. Saarialho–Kere Human TIMP-3 Is Expressed During Fetal Development, Hair Growth Cycle, and Cancer Progression J. Histochem. Cytochem., April 1, 1998; 46(4): 437 - 448. [Abstract] [Full Text]

				M. P. Emert, C. M. Sorenson, D. P. Basile, J. G. Rogers, M. R. Hammerman, and J. J. Billadello The human plasminogen activator inhibitor type I gene promoter targets to kidney Am J Physiol Renal Physiol, February 1, 1998; 274(2): F405 - F412. [Abstract] [Full Text] [PDF]

				K. R. BEREND, A. P. TOTH, J. M. HARRELSON, L. J. LAYFIELD, L. A. HEY, and S. P. SCULLY Association between Ratio of Matrix Metalloproteinase-1 to Tissue Inhibitor of Metalloproteinase-1 and Local Recurrence, Metastasis, and Survival in Human Chondrosarcoma J. Bone Joint Surg. Am., January 1, 1998; 80(1): 11 - 7. [Abstract] [Full Text] [PDF]

				O Eickelberg, C. Sommerfeld, C Wyser, M Tamm, F Reichenberger, P. Bardin, M Soler, M Roth, and A. Perruchoud MMP and TIMP expression pattern in pleural effusions of different origins Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1987 - 1992. [Abstract] [Full Text]

				E. Duhamel-Clerin, C. Orvain, F. Lanza, J.-P. Cazenave, and C. Klein-Soyer Thrombin Receptor-Mediated Increase of Two Matrix Metalloproteinases, MMP-1 and MMP-3, in Human Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1931 - 1938. [Abstract] [Full Text]

				A. Y. Lee, K. T. Akers, M. Collier, L. Li, A. Z. Eisen, and J. L. Seltzer Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts PNAS, April 29, 1997; 94(9): 4424 - 4429. [Abstract] [Full Text] [PDF]

				P. M. Yao, J.-M. Buhler, M. P. d'Ortho, F. Lebargy, C. Delclaux, A. Harf, and C. Lafuma Expression of Matrix Metalloproteinase Gelatinases A and B by Cultured Epithelial Cells from Human Bronchial Explants J. Biol. Chem., June 28, 1996; 271(26): 15580 - 15589. [Abstract] [Full Text] [PDF]

				Y. Maeshima, P. C. Colorado, A. Torre, K. A. Holthaus, J. A. Grunkemeyer, M. B. Ericksen, H. Hopfer, Y. Xiao, I. E. Stillman, and R. Kalluri Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane J. Biol. Chem., July 7, 2000; 275(28): 21340 - 21348. [Abstract] [Full Text] [PDF]

				M. Papetti and I. M. Herman Mechanisms of normal and tumor-derived angiogenesis Am J Physiol Cell Physiol, May 1, 2002; 282(5): C947 - C970. [Abstract] [Full Text] [PDF]